RENN [Renren] UPLOAD:
[]
IDI [IDI] 6-K: (Revised) Tiger Medias iScreenNIKE Storm Sweeps Over Shanghai
[(Revised) Tiger Medias iScreenNIKE Storm Sweeps Over Shanghai Last Game Nike Football SHANGHAI, CHINA June 19, 2014 Tiger Media, Inc. (Tiger Media or the Company) (NYSE MKT: IDI), a Shanghai-based nationwide multi-platform media company, today announced an outdoor digital media blitz for Nikes football (soccer) inspired animated film the Last Game using its entire iScreen network, the outdoor] [FORM 6-K June 19, 2014 Tiger Media, Inc. Cayman Islands (Jurisdiction of incorporation or organization) Room 450, East Office Tower, Shanghai Centre, No.1376 Nan Jing W. Road x x n/a Tiger Media, Inc. Peter W.H. Tan Peter W.H. Tan Chief Executive Officer Description 99.1 Press Release (as revised) dated June 19, 2014.]
ONP [Orient Paper] CORRESP: (Original Filing)
[Orient Paper, Inc. Science Park, Juli Road, Xushui County, Baoding City Hebei Province, P.R. China 072550 June 24, 2014 VIA EDGAR AND EMAIL 100 F Street NE Attention: Anne Nguyen Parker, Branch Chief Norman von Holtzendorff, Senior Counsel Re: Orient Paper, Inc. File No. Ladies and Gentlemen: · · · Please contact Jack I. Kantrowitz of DLA Piper LLP (US),]
ONP [Orient Paper] CORRESP: Orient Paper, Inc. Science Park, Juli Road, Xushui
[Orient Paper, Inc. Science Park, Juli Road, Xushui County, Baoding City Hebei Province, P.R. China 072550 June 24, 2014 VIA EDGAR AND EMAIL 100 F Street NE Attention: Anne Nguyen Parker, Branch Chief Norman von Holtzendorff, Senior Counsel Re: Orient Paper, Inc. File No. Ladies and Gentlemen: · · · Please contact Jack I. Kantrowitz of DLA Piper LLP (US),]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV) -- Collaborating with World Health Organization and Intravacc to Develop sIPV in line with mission to secure a lasting polio-free world, free of all paralytic polio disease Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV) Collaborating] [Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results BEIJING, May 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2014, after market closes on Wednesday, May 21, 2014 EDT. The Company] [Sinovac Reports Unaudited First Quarter 2014 Financial Results -- -Conference call scheduled for Thursday, May 22, 2014 at 8:00 AM EDT Sinovac Reports Unaudited First Quarter 2014 Financial Results - Conference call scheduled for Thursday, May 22, 2014 at 8:00 AM EDT - BEIJING, May 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products] []
SVA [SINOVAC BIOTECH] 6-K: Sinovac Enters Technology Transfer Agreement with Intravacc to
[Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV) -- Collaborating with World Health Organization and Intravacc to Develop sIPV in line with mission to secure a lasting polio-free world, free of all paralytic polio disease Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV) Collaborating] [Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results BEIJING, May 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2014, after market closes on Wednesday, May 21, 2014 EDT. The Company] [Sinovac Reports Unaudited First Quarter 2014 Financial Results -- -Conference call scheduled for Thursday, May 22, 2014 at 8:00 AM EDT Sinovac Reports Unaudited First Quarter 2014 Financial Results - Conference call scheduled for Thursday, May 22, 2014 at 8:00 AM EDT - BEIJING, May 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products] []
